immunotherapy
209 projects
H2020Individual fellowship2017–2019Belgium
NMR4Nanos · Development and application of NMR-based tools to inorganic nanocarriers for effective vaccine delivery
H2020Individual fellowship2017–2020Germany
BITCAT · Blocking Inhibition of T-cell Co-stimulation for Anti-tumour Therapy
2 partners · 2 countries
H2020Doctoral network2017–2021Spain
EN_ACTI2NG · European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry
13 partners · 5 countries
H2020Individual fellowship2017–2018United Kingdom
FLUORODRUGS · Smart Theranostic Agents for the Tumour Microenvironment
H2020Individual fellowship2017–2019Belgium
EC GNG metabolism · Endothelial Gluconeogenesis: a novel target for tumor anti-angiogenesis?
H2020Individual fellowship2017–2019France
DISTRICT · DECIPHERING THE ROLE OF TRIB1 IN REGULATORY T CELLS
H2020Individual fellowship2017–2019United Kingdom
PIM PROTEOMICS · Unravelling PIM kinase signal integration in the T cell response
H2020Individual fellowship2017–2018United Kingdom
iGEMMdev · Development and Characterisation of New Immunogenic GEMMs of Lung Cancer
H2020Individual fellowship2017–2019France
MCNTMTDC · Metabolic control on NF-κB activity during dendritic cells-mediated immune tolerance to tumours
H2020Individual fellowship2016–2018Switzerland
STRAVIR · Role of the stroma-derived ‘alarmin’ IL-33 in anti-viral immunity
H2020Individual fellowship2016–2018United Kingdom
FIBROCAN · Defining the immunological interplay between fibroblastic reticular cells and anti-tumour T cells
H2020Individual fellowship2016–2018Netherlands
ADHERE · Aptamer nanostructures dual-targeted to the HER receptor family for cancer therapy
H2020Individual fellowship2016–2018Sweden
AVITAG · Alphaviral Immunotherapy against Glioblastoma
H2020Individual fellowship2016–2018France
GLUTORHIV · Glucose metabolism and mTOR pathway role in CD8+ T cell control of HIV-1
H2020Individual fellowship2016–2019United Kingdom
HONEYDIAB-8 · Characterization of islet-specific CD8 T cells in the honeymoon of type 1 diabetes
H2020Individual fellowship2016–2018United Kingdom
M6Abolic-RNA-duplex · Metabolic control of RNA-protein and RNA-RNA interactions in cellular transformation.
H2020Doctoral network2016–2019Netherlands
ISPIC · Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome
14 partners · 6 countries
H2020Individual fellowship2016–2018United Kingdom
TIPPDECRA · Tolerogenic immunotherapy with peptide-pulsed dendritic cells in rheumatoid arthritis
H2020Individual fellowship2016–2019United Kingdom
SO-CMA · Improving the safety of oral immunotherapy for cow's milk allergy in children
H2020Doctoral network2015–2019Germany
ENLIGHT-TEN · European Network linking informatics and genomics of helper T cells
18 partners · 8 countries
H2020Doctoral network2015–2019Germany
IMMUTRAIN · Training Network for the Immunotherapy of Cancer
10 partners · 8 countries
H2020Doctoral network2015–2019United Kingdom
MELGEN · MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival
6 partners · 5 countries
H2020Doctoral network2015–2019Netherlands
VIRION · Viruses, Immune stimulation and RNA Interference in Oncology Network
9 partners · 4 countries
H2020Individual fellowship2015–2017Italy